|
INN ▲
|
ATC Code ▲
|
Country ▲
|
Classification ▲
|
Last update ▼
|
MA Number ▲
|
Registration date ▲
|
Status ▲
|
|
VOLANESORSEN |
C10AX18 |
PT
|
POM
|
10-12-2024 |
|
|
VALID
|
|
ALIROCUMAB |
C10AX14 |
PT
|
POM
|
09-12-2024 |
EMEA/H/C/003882 |
23-09-2015 |
VALID
|
|
BEMPEDOIC ACID |
C10AX15 |
PT
|
POM
|
09-12-2024 |
EMEA/H/C/004958 |
01-04-2020 |
VALID
|
|
EVOLOCUMAB |
C10AX13 |
PT
|
POM
|
09-12-2024 |
|
|
VALID
|
|
EZETIMIBE |
C10AX09 |
PT
|
POM
|
09-12-2024 |
|
|
VALID
|
|
ACIPIMOX |
C10AD06 |
PT
|
Not authorised
|
06-12-2024 |
|
|
VALID
|
|
CIPROFIBRATE |
C10AB08 |
PT
|
Not authorised
|
05-12-2024 |
PT/H/0575/001/DC |
19-07-2013 |
VALID
|
|
COLESTYRAMINE |
C10AC01 |
PT
|
POM
|
05-12-2024 |
|
|
VALID
|
|
ATORVASTATIN |
C10AA05 |
PT
|
POM
|
04-12-2024 |
PT/H/0347/004/ |
24-04-2015 |
VALID
|
|
PITAVASTATIN |
C10AA08 |
PT
|
POM
|
04-12-2024 |
|
|
VALID
|
|
ROSUVASTATIN |
C10AA07 |
PT
|
POM
|
04-12-2024 |
PT/H/1127/004/ |
18-07-2014 |
VALID
|
|
SIMVASTATIN |
C10AA01 |
PT
|
POM
|
04-12-2024 |
|
|
VALID
|
|
LOVASTATIN |
C10AA02 |
PT
|
POM
|
03-12-2024 |
|
|
VALID
|
|
PRAVASTATIN |
C10AA03 |
PT
|
POM
|
03-12-2024 |
PT/H/0674/003/ |
11-07-2012 |
VALID
|
|
CEFEPIME AND BETA-LACTAMASE INHIBITOR |
J01DE51 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005431 |
21-03-2024 |
VALID
|
|
DIFELIKEFALIN |
V03AX04 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005612 |
25-04-2022 |
VALID
|
|
EFGARTIGIMOD ALFA |
L04AA58 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005849 |
10-08-2022 |
VALID
|
|
ELRANATAMAB |
L01FX32 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005908 |
07-12-2023 |
VALID
|
|
LEBRIKIZUMAB |
D11AH10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005894 |
16-11-2023 |
VALID
|
|
MARIBAVIR |
J05AX10 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005787 |
09-11-2022 |
VALID
|
|
REZAFUNGIN |
J02AX08 |
PT
|
POM
|
28-10-2024 |
EMEA/H/C/005900 |
22-12-2023 |
VALID
|
|
ADAGRASIB |
L01XX77 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006013 |
05-01-2024 |
VALID
|
|
ASCIMINIB |
L01EA06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005605 |
25-08-2022 |
VALID
|
|
ATIDARSAGENE AUTOTEMCEL |
A16AB21 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005321 |
17-12-2020 |
VALID
|
|
ATOGEPANT |
N02CD07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005871 |
11-08-2023 |
VALID
|
|
AVACOPAN |
L04AJ05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005523 |
11-01-2022 |
VALID
|
|
AVALGLUCOSIDASE ALFA |
A16AB22 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005501 |
24-06-2022 |
VALID
|
|
AZTREONAM AND BETA-LACTAMASE INHIBITOR |
J01DF51 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006113 |
22-04-2024 |
VALID
|
|
BEVACIZUMAB |
S01LA08 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005723 |
27-05-2024 |
VALID
|
|
CAPIVASERTIB |
L01EX27 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006017 |
17-06-2024 |
VALID
|
|
CAPMATINIB |
L01EX17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004845 |
20-06-2022 |
VALID
|
|
CASIRIVIMAB AND IMDEVIMAB |
J06BD07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005814 |
12-11-2021 |
VALID
|
|
CILTACABTAGENE AUTOLEUCEL |
L01XL05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005095 |
25-05-2022 |
VALID
|
|
CROVALIMAB |
L04AJ07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006061 |
22-08-2024 |
VALID
|
|
DASIGLUCAGON |
H04AA02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006214 |
24-07-2024 |
VALID
|
|
DELGOCITINIB |
D11AH11 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006109 |
19-09-2024 |
VALID
|
|
DENGUE VIRUS VACCINES |
J07BX04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005155 |
05-12-2022 |
VALID
|
|
DEUCRAVACITINIB |
L04AF07 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005755 |
24-03-2023 |
VALID
|
|
DOPAMINE |
C01CA04 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006044 |
27-05-2024 |
VALID
|
|
EFANESOCTOCOG ALFA |
B02BD02 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005968 |
17-06-2024 |
VALID
|
|
ELAFIBRANOR |
A05AX06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006231 |
19-09-2024 |
VALID
|
|
ENFORTUMAB VEDOTIN |
L01FX13 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005392 |
13-04-2022 |
VALID
|
|
EPTINEZUMAB |
N02CD05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005287 |
24-01-2022 |
VALID
|
|
ERDAFITINIB |
L01EN01 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006050 |
22-08-2024 |
VALID
|
|
ETRASIMOD |
L04AE05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/006007 |
16-02-2024 |
VALID
|
|
EXAGAMGLOGENE AUTOTEMCEL |
B06AX05 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005763 |
09-02-2024 |
VALID
|
|
FARICIMAB |
S01LA09 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005642 |
15-09-2022 |
VALID
|
|
FERROUS SULFATE AND FOLIC ACID |
B01AD03 |
PT
|
POM
|
22-10-2024 |
PT/H/0171/001/DC |
26-11-2007 |
VALID
|
|
FEZOLINETANT |
G02CX06 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/005851 |
07-12-2023 |
VALID
|
|
FIDANACOGENE ELAPARVOVEC |
B02BD17 |
PT
|
POM
|
22-10-2024 |
EMEA/H/C/004774 |
24-07-2024 |
VALID
|